Spegra Tablet

Spegra Tablet Specification

Origin of Medicine
India

Salt Composition
Dolutegravir, Emtricitabine, and Tenofovir Alafenamide

Dosage Form
Oral route

Drug Type
Specific Drug

Ingredients
Spegra Tablet is a combination antiretroviral medication used for the treatment of HIV (Human Immunodeficiency Virus) infection. Dolutegravir, Emtricitabine, and Tenofovir Alafenamide are its three active ingredients; they all perform together to inhibit viral replication and boost immunity. Consult your doctor if pregnant, breastfeeding, or with any health condition before starting treatment. HIV-positive patients should avoid breastfeeding, sharing personal items, and follow safe sex practices to prevent transmission.

Physical Form
Tablets

Function
Anti-Viral

Recommended For
Adults

Dosage
50/200/25mg

Dosage Guidelines
As suggested by your healthcare provider

Suitable For
Teenagers, Women, Adults, Aged Person

Storage Instructions
Store at normal temperature

Spegra Tablet Trade Information

Minimum Order Quantity
10 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
50 Pieces Per Week

Delivery Time
4 Days

Sample Policy
Contact us for information regarding our sample policy

Main Domestic Market
All India, South India, Gujarat, Karnataka, Kerala, Andhra Pradesh, Odisha, Punjab, Assam, Delhi, Haryana, Madhya Pradesh, Maharashtra, Rajasthan, Tamil Nadu, Telangana, Tripura, Pondicherry, Uttar Pradesh, Uttarakhand, West Bengal

About Spegra Tablet

Spegra Tablet is a combination antiretroviral medication used for the treatment of HIV (Human Immunodeficiency Virus) infection. Dolutegravir, Emtricitabine, and Tenofovir Alafenamide are its three active ingredients; they all perform together to inhibit viral replication and boost immunity.

Consult your doctor if pregnant, breastfeeding, or with any health condition before starting treatment. HIV-positive patients should avoid breastfeeding, sharing personal items, and follow safe sex practices to prevent transmission.

Brand Name: Spegra

Composition: Dolutegravir, Emtricitabine, and Tenofovir Alafenamide

Mechanism of Action:

Dolutegravir: Prevents the integration of viral DNA into the host genome, which is essential for the virus's replication, by inhibiting the integrase enzyme.
Emtricitabine: Prevents viral RNA from being converted to DNA by inhibiting the reverse transcriptase enzyme. Like emtricitabine, tenofovir alafenamide works against HIV by blocking the virus's ability to replicate by inhibiting reverse transcriptase.

Uses:

HIV Infection

Dosage and Administration:

One tablet taken once a day, with or without food, is the usual dosage.

Side Effects: